Last evening, during the 29th Annual Maryland Policy and Leadership Dinner, the Technology Council of Maryland, Inc. (TCM) and the Chesapeake Regional Tech Council (CRTC) announced a merger of the two organizations, effective immediately. The merger is designed to expand and regionalize Maryland’s technology and life science hubs, while also creating a consistent, unified voice for the industries statewide and a platform to attract more companies and leverage synergies.
“This is an exciting and obvious next step for our region—bringing together two powerhouse councils under one roof to benefit the tech and life science industries in our region,” said Tech Council of Maryland Chairman Rene B. LaVigne, President & Chief Executive Officer, Iron Bow Technologies. “We believe this will propel Maryland to become one of the elite hubs in the country for the life science and technology industries. We also believe that together, we will create a larger technology footprint in the region.”
Along with announcing a merger of two of the state’s big tech councils on Tuesday night in Annaoplis, Gov. Larry Hogan talked about how the state wants to help the tech community.
He talked about meeting with Israeli cybersecurity companies during a trip last year and opening the upgraded version of the MdBio Foundation’s mobile eXploration lab earlier that day.
Intrexon Corporation (NYSE: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today announced that it has entered into a definitive agreement to acquire GenVec, Inc. (NASDAQ: GNVC), a clinical-stage company and pioneer in the development of AdenoVerse™ gene delivery technology.
Redox, a Madison, WI-based startup that develops digital tools that enable healthcare applications to access data from electronic health records systems, says it has raised $9 million from investors.
New York-based RRE Ventures led the Series B financing. Other participants in the funding round included return backers .406 Ventures (in Boston), HealthX Ventures (Madison), and Flybridge Capital Partners, which has offices in Boston and New York. .406 Ventures led Redox’s $3.5 million Series A round, which was announced in late 2015.
The Germany Federal Ministry of Health’s Paul-Ehrlich-Institut (PEI) has approved Emergent BioSolutions’ (EBS -1.4%) large-scale Lansing, MI-based manufacturing site, Building 55, that will make its anthrax vaccine BioThrax. The approval allows product made there to be marketed in Germany, the only anthrax vaccine so licensed.
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, today announced the issuance on January 24, 2017 of a seventh patent (number 9,549,940) by the United States Patent and Trademark Office (USPTO) covering Trokendi XR®, its novel once-daily extended-release topiramate product. The patent provides protection for the product with expiration that is no earlier than 2027.
A Johns Hopkins initiative has grant money available for research projects that take a cross-disciplinary approach to urban policies and issues.
The 21st Century Cities program has seven grants available of about $35,000 each, according to the JHU Hub. The projects must have Johns Hopkins faculty members acting as leads, but also must include a community organization or business.
The Greater Washington Partnership, a group of chief executives and business leaders from the Baltimore-Washington area, has tapped a former White House staffer as its CEO.
Jason Miller, who previously worked as deputy assistant to the President and Deputy Director of the National Economic Council, begins his tenure as CEO of the newly formed business group April 1.
The MdBio Foundation, a non-profit that provides STEM education and workforce development to underserved communities, will unveil its new mobile laboratory, the Mobile eXploration Lab (MXLab), in Annapolis, Md., on January 24. The event will include an open house and tour of the MXLab, as well as a ribbon cutting ceremony featuring Gov. Larry Hogan, state officials and business leaders.
The MXLab is the largest mobile laboratory of its kind in the U.S. and will enable MdBio to expand its mission of giving students the opportunity to experience hands-on science, technology, engineering and math (STEM) education. The lab provides students with access to cutting-edge technologies and techniques not typically available at schools and experience with practical, real-world applications in use by today’s scientific and tech communities.
NHLBI seeks to facilitate and accelerate the development of new clinical interventions by bridging the gaps between mechanistic, discovery, and early translational research. This includes providing appropriate mechanisms to support investigator-initiated research, addressing resource and knowledge gaps, and creating initiatives to support career development of translational scientists and biomedical entrepreneurs.
The NHLBI is considering providing support for the earliest phases of developing a target/compound/biologic for use as a therapy or diagnostic. It is envisioned that projects assisted by such a program would be investigator-initiated grants of relatively short duration, designed to answer one to two specific questions (which may or may not be hypothesis driven), and focused on whether the target in question is reasonable to pursue as a therapy or diagnostic.
When: Thursday February 16, 2017 from 5:00 PM to 7:00 PM EST
Location: Growlers 227 E Diamond Ave Gaithersburg, MD 20877
Johns Hopkins Montgomery County Campus is also a site for the popular Osher Lifelong Learning Institute. Geared toward retirees, these non-credit classes cover topics including opera, literature, history, politics and more.
The campus is home to approximately 35 research companies and entrepreneurs. Scientists on campus are studying cervical cancer, Alzheimer’s disease, cell therapy, proteins and other health issues. Other companies focus on technology, medical devices and consulting services. The Rockville Science Center’s administrative offices are located here. Start-up companies, second-stage businesses and more established companies are welcome.
From striving to increase sales to recognizing the need for larger facilities, growth is often on the minds of business owners. If you’re a business owner who set out to grow your Maryland business in 2017, use the infographic below as a guide.
A few weeks before I began my freshman year at the Massachusetts Institute of Technology, I received an official- looking envelope from a student group. Expecting information about a club or event, I was surprised to find such sentences as “MIT certainly lowers standards for women and ‘underrepresented’ minorities” and “The average woman at MIT is less intelligent and ambitious than the average man at MIT. The average ‘underrepresented’ minority at MIT is less intelligent and ambitious than the average non-‘underrepresented’ minority.” (MIT’s Association of Student Activities later stripped the student group of its official recognition as a result of the unapproved mailing.)
The coming $1.1 billion acquisition of CoverMyMeds LLC – Ohio’s first tech startup ” unicorn” – is a huge win for the Ohio Third Frontier program.
McKesson Corp., one of the three biggest U.S. health-care products distributors, announced Wednesday it would acquire the fast-growing Columbus software maker in a deal that could grow to $1.37 billion depending on its financial performance over the next two years.
Pig embryos that had been injected with human stem cells when they were only a few days old began to grow organs containing human cells, scientists reported on Thursday, an advance that promises — or threatens — to bring closer the routine production of creatures that are part human and part something else.
Computers can classify skin cancers as successfully as human experts, according to the latest research attempting to apply artificial intelligence to health.
The US-based researchers say the new system, which is based on image recognition, could be developed for smartphones, increasing access to screening and providing a low-cost way to check whether skin lesions are cause for concern.
EVERY year about 120,000 organs, mostly kidneys, are transplanted from one human being to another. Sometimes the donor is a living volunteer. Usually, though, he or she is the victim of an accident, stroke, heart attack or similar sudden event that has terminated the life of an otherwise healthy individual. But a lack of suitable donors, particularly as cars get safer and first-aid becomes more effective, means the supply of such organs is limited. Many people therefore die waiting for a transplant. That has led researchers to study the question of how to build organs from scratch.
Introducing The Medical Capital Innovation Competition to be held April 25-26, 2017 at the Global Center for Health Innovation, Cleveland OH in the HIMSS Innovation Center. Where innovators with big ideas on the collection, management, analysis and optimization of healthcare big data can submit their idea(s) and present their innovation.
With $100,000 in cash prizes, the competition will reward the best innovations with meaningful funding, mentoring, and potential access to three world class healthcare systems and collaborators who can turn big ideas into new big business realities. The Medical Capital Innovation Competition is open to and encourages participation from professional and collegiate teams.
Dr. Patrick Soon-Shiong, an audacious biotech billionaire who has pledged to “solve health care,” has been in talks with the Trump administration about the possibility of serving in a senior role overseeing the US health care system, according to individuals familiar with the discussions.
Soon-Shiong, a trained surgeon, has met with President Trump and his advisers at least twice in recent weeks. During those discussions, he raised the possibility that he could serve as a “health care czar” with a broad portfolio in the administration as it seeks to reshape the health care system and replace the Affordable Care Act, according to two individuals, who spoke on the condition of anonymity.
“John knows exactly what he’s doing and needs little management. He works rapidly but without any mistakes so he delivers an amazing amount of high quality work. No one can do what he does.”
This was the response I received when I asked a manager how John was doing. Sounds good, doesn’t it? Read on.
In a unique collaboration, a concurrent degree program featuring Penn State Harrisburg’s master of business administration and the Penn State College of Medicine’s doctorate in biomedical sciences allows students to get on a fast track to jobs that combine scientific research with positions of management responsibility. The concurrent program gives students an edge in a highly competitive field by providing them with a foundation in management in addition to specialization in biomedical science.
You’ve got an amazing idea for a new medical product, it’ll save lives, speed recovery, be less expensive, more accurate and durable than the product already available on the market – or it may fill a gap where there is no product available. You have an amazing team, strong IP, an understanding of the regulatory and reimbursement coverage data requirements – all you need to get to market is MORE MONEY! In this Small Biz Hangout one of NHLBI’s funded companies will demonstrate how to deliver a strong pitch to investors and our Investor-in-Residence will comment on the most effective and impactful aspects of the delivery.
BDO and Crowell & Moring are proud to present a two-part panel discussion on IP Strategy for the BioPharma Industry. This is a “must attend” event for companies engaged in drug, vaccine, biologic, or medical device research and strategic product development. IP and the strategy to procure and sustain it is one of the most critical aspects to revenue generation and commercial success. Our panel members are admired veterans in this field and will present intriguing case studies that will emphasize lessons learned and practical solutions to creating a successful IP strategy.
Combining motherhood and a career is a juggling act, and was even more so before the breast pump. Women didn’t always have access to pumps in the workplace, however nowadays many breastfeeding mothers rely on a breast pump when returning to work to help extend breastfeeding and the work/life balance. Join us as Debra Kurtz, President, Kurtz Consulting Inc, discusses:
the history of breast pump innovation
how these class II medical devices assist with maternal employment
leverage user insights to drive product requirements and IP strategy
the opportunities we have to improve health products, advance employee benefits, and improve work/life balance for future generations of women
Over 70% of previous attendees surveyed say that CONNECTpreneur is the “Number One” tech and investor event in the Mid-Atlantic region!
DCInno calls CONNECTpreneur “The Best Networking Event in the region” and a “NETWORKING JACKPOT” of the area’s TOP Entrepreneurs, Business Leaders, CXOs, Angels, and VCs.
Presented by Tech 2000 and LORE Systems, this UNIQUE EVENT is like NONE OTHER in our region, because of the high quality of our attendees, speakers and presenters.
So, here we are: With a new president come new concerns over surveillance powers that could so forcefully bite us in the ass.
The public has good reason to believe that President Donald Trump would love to expand data-collection programs in his administration. He’s said, repeatedly, that he’d like to surveil mosques. Rep. Mike Pompeo—Trump’s pick for CIA director who’s likely to be confirmed in the next few days—has also advocated for expanded spy efforts. All signs point to lots of little electronic eyeballs, watching us always.
President Donald Trump’s hiring freeze will last only as long as it takes his administration to come up with an alternative attrition plan, according to a memorandum released by the White House Monday, and could provide broad exemptions for agency leaders.
Trump said his hiring moratorium would “be applied across the board in the executive branch” and apply to any positions vacant as of Jan. 22. It would bar agencies from creating new positions. Agency heads can exempt positions they deem “necessary to meet national security or public safety responsibilities.”
The information contained in this website and newsletters is for general information purposes only. The information is provided by BioHealth Innovation via its newsletters, but not written or endorsed in any way by BioHealth Innovation unless otherwise noted. While we endeavor to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
